Literature DB >> 25069439

MicroRNAs as main players in the pathogenesis of chronic lymphocytic leukemia.

Arianna Bottoni, George A Calin1.   

Abstract

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. The accumulation of mature CD5(+) B-lymphocytes in bone marrow, peripheral blood, and lymphoid organs due to decreased apoptosis is a characteristic of this malignancy. MicroRNAs (miRNAs) are small noncoding RNAs able to regulate the expression of many target genes, including the main apoptosis regulators BCL2 and MCL1. miRNAs play key roles in the pathogenesis of CLL, including specific miRNAs located at the 13q14 chromosomal region that is often deleted or mutated in patients with CLL. In this paper, we review new investigations that underscore the significance of miRNAs for CLL pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25069439     DOI: 10.2174/2211536602666131126002337

Source DB:  PubMed          Journal:  Microrna


  10 in total

1.  miRNAs differentially expressed by next-generation sequencing in cord blood buffy coat samples of boys and girls.

Authors:  Daneida Lizarraga; Karen Huen; Mary Combs; Maria Escudero-Fung; Brenda Eskenazi; Nina Holland
Journal:  Epigenomics       Date:  2016-11-24       Impact factor: 4.778

Review 2.  Future of environmental research in the age of epigenomics and exposomics.

Authors:  Nina Holland
Journal:  Rev Environ Health       Date:  2017-03-01       Impact factor: 3.458

Review 3.  MicroRNAs in chronic lymphocytic leukemia: miRacle or miRage for prognosis and targeted therapies?

Authors:  Katrien Van Roosbroeck; George A Calin
Journal:  Semin Oncol       Date:  2016-02-08       Impact factor: 4.929

Review 4.  CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.

Authors:  Margot Zöller
Journal:  Front Immunol       Date:  2015-05-26       Impact factor: 7.561

5.  Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia.

Authors:  Oxana Dobrovinskaya; Georgina Valencia-Cruz; Luis Castro-Sánchez; Edgar O Bonales-Alatorre; Liliana Liñan-Rico; Igor Pottosin
Journal:  Front Pharmacol       Date:  2016-08-31       Impact factor: 5.810

6.  Expression of circulating miRNAs associated with lymphocyte differentiation and activation in CLL-another piece in the puzzle.

Authors:  Agata A Filip; Anna Grenda; Sylwia Popek; Dorota Koczkodaj; Małgorzata Michalak-Wojnowska; Michał Budzyński; Ewa Wąsik-Szczepanek; Szymon Zmorzyński; Agnieszka Karczmarczyk; Krzysztof Giannopoulos
Journal:  Ann Hematol       Date:  2016-10-12       Impact factor: 3.673

7.  Microenvironment regulates the expression of miR-21 and tumor suppressor genes PTEN, PIAS3 and PDCD4 through ZAP-70 in chronic lymphocytic leukemia.

Authors:  Júlia Carabia; Cecilia Carpio; Pau Abrisqueta; Isabel Jiménez; Noelia Purroy; Eva Calpe; Carles Palacio; Francesc Bosch; Marta Crespo
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

Review 8.  Role of non-coding RNA networks in leukemia progression, metastasis and drug resistance.

Authors:  Ajaz A Bhat; Salma N Younes; Syed Shadab Raza; Lubna Zarif; Sabah Nisar; Ikhlak Ahmed; Rashid Mir; Sachin Kumar; Surender K Sharawat; Sheema Hashem; Imadeldin Elfaki; Michal Kulinski; Shilpa Kuttikrishnan; Kirti S Prabhu; Abdul Q Khan; Santosh K Yadav; Wael El-Rifai; Mohammad A Zargar; Hatem Zayed; Mohammad Haris; Shahab Uddin
Journal:  Mol Cancer       Date:  2020-03-12       Impact factor: 27.401

9.  MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia.

Authors:  Zhu Xishan; Lin Ziying; Du Jing; Liu Gang
Journal:  Sci Rep       Date:  2015-07-31       Impact factor: 4.379

10.  Relationship between Chromosomal Aberrations and Gene Expressions in the p53 Pathway in Chronic Lymphocytic Leukemia.

Authors:  G Öztan; M Aktan; S Palanduz; H İşsever; S Öztürk; E Nikerel; A Uçur; G Bağatir; A Bayrak; K Çefle
Journal:  Balkan J Med Genet       Date:  2020-08-26       Impact factor: 0.519

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.